E. Schillinger

1.3k total citations
58 papers, 1.1k citations indexed

About

E. Schillinger is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Pharmacology. According to data from OpenAlex, E. Schillinger has authored 58 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 19 papers in Endocrinology, Diabetes and Metabolism and 17 papers in Pharmacology. Recurrent topics in E. Schillinger's work include Hormonal Regulation and Hypertension (12 papers), Estrogen and related hormone effects (12 papers) and Inflammatory mediators and NSAID effects (10 papers). E. Schillinger is often cited by papers focused on Hormonal Regulation and Hypertension (12 papers), Estrogen and related hormone effects (12 papers) and Inflammatory mediators and NSAID effects (10 papers). E. Schillinger collaborates with scholars based in Germany, United States and Australia. E. Schillinger's co-authors include Peter Muhn, Rolf Krattenmacher, Ulrike Fuhrmann, Werner Skuballa, Karl Heinrich Fritzemeier, J. Casals‐Stenzel, H. Vorbrueggen, W. Elger, S. Beier and Rudolf Wiechert and has published in prestigious journals such as Annals of the New York Academy of Sciences, Journal of Medicinal Chemistry and American Journal of Obstetrics and Gynecology.

In The Last Decade

E. Schillinger

56 papers receiving 931 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Schillinger Germany 18 256 253 243 236 168 58 1.1k
Arun K. Agrawal United States 20 445 1.7× 161 0.6× 314 1.3× 43 0.2× 71 0.4× 37 1.4k
Robert J. DeVita United States 26 280 1.1× 255 1.0× 770 3.2× 115 0.5× 67 0.4× 71 1.8k
S. Beier Germany 14 277 1.1× 320 1.3× 170 0.7× 24 0.1× 229 1.4× 29 909
Leonard J. Lerner Malaysia 15 189 0.7× 567 2.2× 232 1.0× 96 0.4× 144 0.9× 49 1.0k
Ruth A. Henderson United States 12 153 0.6× 690 2.7× 329 1.4× 90 0.4× 54 0.3× 15 1.4k
Masami Nemoto Japan 16 245 1.0× 243 1.0× 1.0k 4.3× 82 0.3× 55 0.3× 54 1.8k
Kapila Ratnam United States 12 462 1.8× 215 0.8× 571 2.3× 74 0.3× 41 0.2× 15 1.4k
Hussein Abou‐Issa United States 21 103 0.4× 673 2.7× 663 2.7× 683 2.9× 49 0.3× 58 1.8k
N. T. Shahidi United States 14 232 0.9× 153 0.6× 314 1.3× 78 0.3× 34 0.2× 38 950
Agneta Blanck Sweden 20 127 0.5× 126 0.5× 367 1.5× 36 0.2× 71 0.4× 64 1.2k

Countries citing papers authored by E. Schillinger

Since Specialization
Citations

This map shows the geographic impact of E. Schillinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Schillinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Schillinger more than expected).

Fields of papers citing papers by E. Schillinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Schillinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Schillinger. The network helps show where E. Schillinger may publish in the future.

Co-authorship network of co-authors of E. Schillinger

This figure shows the co-authorship network connecting the top 25 collaborators of E. Schillinger. A scholar is included among the top collaborators of E. Schillinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Schillinger. E. Schillinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Muhn, Peter, Rolf Krattenmacher, S. Beier, W. Elger, & E. Schillinger. (1995). Drospirenone: A novel progestogen with antimineralocorticoid and antiandrogenic activity. Contraception. 51(2). 99–110. 107 indexed citations
2.
Gopalkrishnan, K., et al.. (1995). Onapristone (ZK 98.299): A potential antiprogestin for endometrial contraception. American Journal of Obstetrics and Gynecology. 173(3). 779–787. 40 indexed citations
3.
Muhn, Peter, Ulrike Fuhrmann, Karl Heinrich Fritzemeier, Rolf Krattenmacher, & E. Schillinger. (1995). Drospirenone: a Novel Progestogen with Antimineralocorticoid and Antiandrogenic Activity. Annals of the New York Academy of Sciences. 761(1). 311–335. 151 indexed citations
4.
Fuhrmann, Ulrike, et al.. (1992). Stable transfection of androgen receptor and MMTV-CAT into mammalian cells: Inhibition of cat expression by anti-androgens. The Journal of Steroid Biochemistry and Molecular Biology. 42(8). 787–793. 40 indexed citations
5.
Nickisch, Klaus, S. Beier, W. Elger, et al.. (1991). Aldosterone antagonists. 4. Synthesis and activities of steroidal 6,6-ethylene-15,16-methylene 17-spirolactones. Journal of Medicinal Chemistry. 34(8). 2464–2468. 16 indexed citations
6.
Nickisch, Klaus, Henry Laurent, Wolfgang Losert, et al.. (1990). Aldosterone antagonists. 3. Synthesis and activities of steroidal 7.alpha.-(alkoxycarbonyl)-15,16-methylene spirolactones. Journal of Medicinal Chemistry. 33(2). 509–513. 17 indexed citations
7.
Becker, K, et al.. (1990). Influence of some prostaglandins and prostaglandin analogues on PAF-induced shock in mice. Prostaglandins Leukotrienes and Essential Fatty Acids. 40(2). 157–160. 1 indexed citations
8.
Stürzebecher, S, et al.. (1989). Effects of PGD2, PGE1, and PGI2-analogues on PGDF-release and aggregation of human gelfiltered platelets.. PubMed. 301. 365–9. 5 indexed citations
9.
Thierauch, K.-H., E. Schillinger, Hartmut Rehwinkel, et al.. (1988). Stable 9ß- or 11α-halogen-15-cyclohexyl-prostaglandins with high affinity to the PGD2-receptor. Prostaglandins. 35(6). 855–868. 34 indexed citations
10.
Skuballa, Werner, et al.. (1986). Prostaglandin analogs. Part 9. Synthesis of a new chemically and metabolically stable prostacyclin analog with high and long-lasting oral activity. Journal of Medicinal Chemistry. 29(3). 313–315. 99 indexed citations
11.
Losert, Wolfgang, J. Casals‐Stenzel, Martin Haberey, et al.. (1986). Mespirenone and other 15,16-methylene-17-spirolactones, a new type of steroidal aldosterone antagonists.. PubMed. 36(11). 1583–600. 24 indexed citations
12.
Holmes, Paul, et al.. (1985). Effects of high and low preovulatory concentrations of progesterone on ovulation from the isolated perfused rabbit ovary. Reproduction. 75(2). 393–399. 24 indexed citations
13.
Neef, Günter, et al.. (1982). Synthesis and pharmacological evaluation of 8α-estradiol derivatives. Steroids. 40(2). 171–187. 29 indexed citations
14.
Beier, S., et al.. (1981). Differences in the pharmacodynamic effects of freeze dried plant extracts against hypophyseal and thyroid hormones in the rat. Naunyn-Schmiedeberg s Archives of Pharmacology. 316. 49. 2 indexed citations
15.
Schillinger, E., et al.. (1980). Prostaglandin I2 receptors in a particulate fraction of platelets of various species. Biochemical Pharmacology. 29(17). 2297–2299. 35 indexed citations
16.
Schillinger, E., et al.. (1978). Stereospecific plasma binding of gliflumide, a new antidiabetic drug. Biochemical Pharmacology. 27(5). 651–653. 7 indexed citations
17.
Schillinger, E., et al.. (1976). Characteristics of prostaglandin receptor sites in human uterine tissue.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 1. 259–63. 20 indexed citations
18.
Lübke, Klaus, et al.. (1976). Hormon‐Rezeptoren. Angewandte Chemie. 88(23). 790–798. 4 indexed citations
19.
Schillinger, E., et al.. (1973). Influence of hormonal contraceptives on carbohydrate and lipid metabolism in the rat. Biochemical Pharmacology. 22(15). 1835–1844. 18 indexed citations
20.
Losert, Wolfgang, et al.. (1972). [Animal experimental studies on the mode of action of biguanides. 1. Studies with hypoglycemia-inducing doses of biguanide].. PubMed. 22(7). 1157–69. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026